MARKET COMPOSITE
LFVN - Lifevantage Corporation9:00:00 PM 2/20/2024
Price
$6.92
+ 0.07 (1.02%)
LifeVantage Corporation engages in the identification, research, development, and distribution of nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, and skin and hair care products. The company offers Protandim, a line of scientifically-validated dietary supplements; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support digestive system health; a line of weight management products under the PhysIQ brand; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a line of energy drink mixes. It also provides anti-aging skin care products, including facial cleansers, perfecting lotions, eye serums, anti-aging creams, and hand creams, as well as hair care products, such as invigorating shampoos, nourishing conditioners, and scalp serums under the LifeVantage TrueScience brand name. The company sells its products through its website, as well as through a network of independent distributors in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand, and China. LifeVantage Corporation is headquartered in Sandy, Utah.
Stock Chart

Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from 

Finra

Moving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.

Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.

Stock news

    SALT LAKE CITY, Feb. 16, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that Steve Fife, President and Chief Executive Officer, and Carl Aure, Chief Financial Officer, will participate in the Winter Wrap Up MicroCap Rodeo Virtual Conference, to be held February 20-23, 2024. Mr. Fife and Mr. Aure will meet with investors and present at approxima

    Enters into Cooperation Agreement with the Radoff-Sudbury GroupSALT LAKE CITY, Feb. 15, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced the appointment of Dayton Judd to the Company’s Board of Directors (the “Board”), effective immediately, in an expansion of the Board. The Company has had discussions with Bradley L. Radoff and Sudbury Capital Fu

    Transformation continues to advance with phase 2 launch of Evolve Compensation Plan and Rewards Circle customer loyalty program on Feb 1, 2024SALT LAKE CITY, Feb. 07, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, proudly announces the successful expansion of LV360 into Canada, Mexico, and its European markets including the UK, Ireland, Germany, Austria, Belgi

    It is hard to get excited after looking at LifeVantage's (NASDAQ:LFVN) recent performance, when its stock has declined...

    LifeVantage Corporation (NASDAQ:LFVN) Q2 2024 Earnings Call Transcript January 30, 2024 LifeVantage Corporation isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, ladies and gentlemen. Thank you for standing by. Welcome to today’s Conference Call to Discuss LifeVantage’s Second […]

    SALT LAKE CITY, Jan. 30, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that the Company’s Board of Directors has approved a quarterly cash dividend of $0.035 per share of common stock, which will be paid March 15, 2024 to all stockholders of record at the close of business on March 1, 2024. About LifeVantage Corporation LifeVantage Corporation

    SALT LAKE CITY, Jan. 30, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today reported financial results for its second fiscal quarter ended December 31, 2023. Second Quarter Fiscal 2024 Summary*: Revenue of $51.6 million, a decrease of 3.8% from the prior year period. Excluding the negative impact of foreign currency fluctuations, second quarter revenue was

    SALT LAKE CITY, Jan. 16, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), a leading health and wellness company with products designed to activate optimal health processes, today announced that it will release financial results for its second quarter ended December 31, 2023, after the stock market closes on Tuesday, January 30, 2024. The Company will hold a conference call for investors at 2:30 p.m. Mountain Time (4:30 p.m. Eastern Time) that same day. Investors interested in part

    Hundreds of Independent Consultants host virtual watch parties to jumpstart 2024SALT LAKE CITY, Jan. 16, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, held its annual Global Kickoff on Saturday, January 13, 2024. This worldwide event featured the announcement of the Company’s “Rise ERA” theme, the unveiling of the launch date for the next phase of LV360, new

    Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...